论文期刊

取消

高级检索

检索历史清除

首页> International journal of molecular sciences> NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells.

NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells.

导出 OA

翻译打印收藏纠错

作者： Vincenzo,Quagliariello ^[1] ; Michelino,De Laurentiis ^[2] ; Stefania,Cocco ^[2] ; Giuseppina,Rea ^[3] ; Annamaria,Bonelli ^[1] ; Antonietta,Caronna ^[1] ; Maria Cristina,Lombari ^[1] ; Gabriele,Conforti ^[1] ; Massimiliano,Berretta ^[4] ; Gerardo,Botti ^[5] ; Nicola,Maurea ^[1]

作者单位： Division of Cardiology, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, 80131 Napoli, Italy. ^[1] Breast Unit, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, 80131 Napoli, Italy. ^[2] UOC Bersagli Molecolari del Microambiente, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, 80131 Naples, Italy. ^[3] Department of MedicalOncology-Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy. ^[4] Scientific Direction, Istituto Nazionale Tumori- IRCCS- Fondazione G. Pascale, 80131 Napoli, Italy. ^[5]

关键词 breast cancer cardioncology cardiotoxicity cytokines hyperglycemia nivolumab

主题词二苯甲基化合物(Benzhydryl Compounds);生物学标记, 药理学(Biomarkers, Pharmacological);细胞系, 肿瘤(Cell Line, Tumor);女(雌)性(Female);葡萄糖(Glucose);葡糖苷类(Glucosides);人类(Humans);高血糖症(Hyperglycemia);白三烯B4(Leukotriene B4);髓样分化因子88(Myeloid Differentiation Factor 88);肌细胞, 心脏(Myocytes, Cardiac);转录因子RelA(Transcription Factor RelA)

DOI 10.3390/ijms21207802

PMID 33096896

发布时间 2024-08-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

International journal of molecular sciences

International journal of molecular sciences

2020年21卷20期

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷